Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Greene

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|December 22, 2017
Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migrationSarah M Ridge, Dibyangana Bhattacharyya, Eoin Dervan, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazoleOlivier Lortholary, Gaelle Obenga, Pinaki Biswas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 13, 2014
Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosisYuyan Han, Paolo Onori, Fanyin Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Initiating oncogenic event determines gene-expression patterns of human breast cancer modelsKartiki V Desai, Nianqing Xiao, Weili Wang, et al.
Scientific Reports|July 11, 2020
Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemnessLouise Flynn, Martin P Barr, Anne-Marie Baird, et al.
Therapeutic Advances in Medical Oncology|September 13, 2021
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label studyRaymond S McDermott, John Greene, John McCaffrey, et al.
The American Journal of Pathology|March 19, 2017
Nicotine Promotes Cholangiocarcinoma Growth in Xenograft MiceAllyson K Martínez, Kendal Jensen, Chad Hall, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2016
Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated miceLindsey L Kennedy, Fanyin Meng, Julie K Venter, et al.
Transfusion|December 6, 2023
Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccinationNareg H Roubinian, John Greene, Vincent X Liu, et al.
Pathology, Research and Practice|September 17, 2025
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinomaMark Bates, Jason McGrath, Laura Byrne, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|December 22, 2017
Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migrationSarah M Ridge, Dibyangana Bhattacharyya, Eoin Dervan, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazoleOlivier Lortholary, Gaelle Obenga, Pinaki Biswas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 13, 2014
Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosisYuyan Han, Paolo Onori, Fanyin Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Initiating oncogenic event determines gene-expression patterns of human breast cancer modelsKartiki V Desai, Nianqing Xiao, Weili Wang, et al.
Scientific Reports|July 11, 2020
Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemnessLouise Flynn, Martin P Barr, Anne-Marie Baird, et al.
Therapeutic Advances in Medical Oncology|September 13, 2021
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label studyRaymond S McDermott, John Greene, John McCaffrey, et al.
The American Journal of Pathology|March 19, 2017
Nicotine Promotes Cholangiocarcinoma Growth in Xenograft MiceAllyson K Martínez, Kendal Jensen, Chad Hall, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2016
Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated miceLindsey L Kennedy, Fanyin Meng, Julie K Venter, et al.
Transfusion|December 6, 2023
Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccinationNareg H Roubinian, John Greene, Vincent X Liu, et al.
Pathology, Research and Practice|September 17, 2025
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinomaMark Bates, Jason McGrath, Laura Byrne, et al.
Pageof 12